incyte corp (INCY:NASDAQ GS)
Earnings & Estimates Summary - INCYTE CORP (INCY)
2013 revenues at Incyte Corporation totaled $354.9M USD, while annual losses equaled $0.44 per share.
Quarterly Earnings & Estimates - INCYTE CORP (INCY)
Incyte Corporation's Quarterly Earnings
Incyte Corporation reported 2nd quarter 2014 on 08/2/2014.
Annual Earnings & Estimates - INCYTE CORP (INCY)
Incyte Corporation's Annual Earnings
Incyte Corporation reported annual 2013 losses of $0.44 per share on 02/14/2014.
Quarterly Revenues - INCYTE CORP (INCY)
Annual Revenues - INCYTE CORP (INCY)
Incyte Corporation's Annual Revenues
Incyte Corporation had revenues for the full year 2013 of $354.9M USD. This was 19.5% above the prior year's results.
|Alkermes PLC||$70.02 USD||+2.49|
|ARIAD Pharmaceuticals Inc||$8.16 USD||+0.31|
|BioMarin Pharmaceutical Inc||$146.27 USD||+1.71|
|Jazz Pharmaceuticals PLC||$192.24 USD||+1.86|
|Vertex Pharmaceuticals Inc||$135.00 USD||-0.46|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|